Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Anticoagulant Therapy in Patients With Atrial Fibrillation After Surgical Left Atrial Appendage Closure: a Randomized Non-inferiority Trial (The ATLAAC Trial)

NCT06401616 is registered in ClinicalTrials.gov with Odense University Hospital as lead sponsor.

NCT NCT06401616
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06401616 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Anticoagulant Therapy in Patients With Atrial Fibrillation After Surgical Left Atrial Appendage Closure: a Randomized Non-inferiority Trial (The ATLAAC Trial)
Lead sponsor
Odense University Hospital
Phase
Phase 4
Overall status
Recruiting
Start date
May 21, 2024
Completion date
March 31, 2028
Enrollment
1,220 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

anticoagulant adverse reaction, atrial fibrillation, left atrial appendage absent